Abstract
Abstract. In a double‐blind trial renal allograft recipients were treated with fibroblast interferon preparations for 3 months in an attempt to prevent viral infections. Interferon therapy did not reduce the overall incidence of viral infections. No adverse effects were noted on liver function, platelet counts. or leucocyte counts, or acute rejection episodes.
Original language | English |
---|---|
Pages (from-to) | 255-258 |
Number of pages | 4 |
Journal | European Journal of Clinical Investigation |
Volume | 8 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Jan 1978 |
Keywords
- Interferon
- renal transplantation
- viral infections